GGrantIndex
← Leaderboards

Zackary I Cleveland

Cincinnati Childrens Hosp Med Ctr

$6,645,866
Attributed
$8,605,681
Total exposure
11
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,605,681 · 11

By mechanism

R01$7,640,410 · 2
R00$728,261 · 1
K99$168,110 · 1
P41$68,900 · 7

Top collaborators

Most similar at Cincinnati Childrens Hosp Med Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Image

Research focus

ImageMagnetic Resonance ImagingLungUnited States National Institutes Of HealthLung DiseasesResolutionGasesMonitorPathologyMolecularMissionDisease ProgressionImpairmentInnovationBaseAnimal ModelAlveolarPublic HealthIn VivoPulmonary FunctionPathologicInflammationFunctional DisorderNovel Therapeutics

Grant awards (22)

Imaging and Molecular Phenotyping of Cystic Fibrosis Lung Disease$789,104
R01 · FY2025 · HL · contact PI
Imaging and Molecular Phenotyping of Cystic Fibrosis Lung Disease$767,868
R01 · FY2024 · HL · contact PI
Imaging and Molecular Phenotyping of Cystic Fibrosis Lung Disease$783,539
R01 · FY2023 · HL · contact PI
Validating Quantitative Magnetic Resonance Imaging Biomarkers of Idiopathic Pulmonary Fibrosis$743,722
R01 · FY2023 · HL · contact PI
Imaging and Molecular Phenotyping of Cystic Fibrosis Lung Disease$789,560
R01 · FY2022 · HL · contact PI
Validating Quantitative Magnetic Resonance Imaging Biomarkers of Idiopathic Pulmonary Fibrosis$751,069
R01 · FY2022 · HL · contact PI
Imaging and Molecular Phenotyping of Cystic Fibrosis Lung Disease$789,560
R01 · FY2021 · HL · contact PI
Validating Quantitative Magnetic Resonance Imaging Biomarkers of Idiopathic Pulmonary Fibrosis$688,240
R01 · FY2021 · HL · contact PI
Validating Quantitative Magnetic Resonance Imaging Biomarkers of Idiopathic Pulmonary Fibrosis$771,092
R01 · FY2020 · HL · contact PI
Validating Quantitative Magnetic Resonance Imaging Biomarkers of Idiopathic Pulmonary Fibrosis$766,656
R01 · FY2019 · HL · contact PI
Time-Resolved 129Xe Ventilation-Perfusion MRI in Models of Acute Lung Injury$236,446
R00 · FY2017 · HL · contact PI
Time-Resolved 129Xe Ventilation-Perfusion MRI in Models of Acute Lung Injury$242,816
R00 · FY2016 · HL · contact PI
Time-Resolved 129Xe Ventilation-Perfusion MRI in Models of Acute Lung Injury$248,999
R00 · FY2015 · HL · contact PI
Time-Resolved 129Xe Ventilation-Perfusion MRI in Models of Acute Lung Injury$84,055
K99 · FY2013 · HL · contact PI
Time-Resolved 129Xe Ventilation-Perfusion MRI in Models of Acute Lung Injury$84,055
K99 · FY2012 · HL · contact PI
3D IMAGING OF GAS EXCHANGE USING HYPERPOLARIZED 129XE MRI$18,408
P41 · FY2011 · RR · contact PI
TESTING AND INVESTIGATION OF M2M IMAGING COIL$6,136
P41 · FY2011 · RR · contact PI
IN VIVO 3D LUNG IMAGING WITH HYPERPOLARIZED 129XENON$6,136
P41 · FY2011 · RR · contact PI
3D IMAGING OF GAS EXCHANGE USING HYPERPOLARIZED 129XE MRI$16,380
P41 · FY2010 · RR · contact PI
TESTING AND INVESTIGATION OF M2M IMAGING COIL$5,460
P41 · FY2010 · RR · contact PI
IN VIVO 3D LUNG IMAGING WITH HYPERPOLARIZED 129XENON$5,460
P41 · FY2010 · RR · contact PI
3D IMAGING OF GAS EXCHANGE USING HYPERPOLARIZED 129XE MRI$10,920
P41 · FY2009 · RR · contact PI